However, there is evidence that CRP levels rise modestly despite active tissue-damaging inflammatory processes in some disorders, including systemic lupus erythematosus, scleroderma, dermatomyositis, Sjögren’s syndrome, ulcerative colitis, graft-versus-host disease and leukemia.1 This evidence concerns the gene CRP and scleroderma.